MorphoSys Stock (NASDAQ:MOR), Analyst Ratings, Price Targets, Predictions

The latest price target for MorphoSys (NASDAQ: MOR) was reported by Wells Fargo on March 14, 2024. The analyst firm set a price target for $18.25 expecting MOR to rise to within 12 months (a possible 1.73% upside). 13 analyst firms have reported ratings in the last year.

The latest analyst rating for MorphoSys (NASDAQ: MOR) was provided by Wells Fargo, and MorphoSys downgraded their equal-weight rating.

The last upgrade for MorphoSys AG happened on October 13, 2023 when Morgan Stanley raised their price target to $9.2. Morgan Stanley previously had an underweight for MorphoSys AG.

The last downgrade for MorphoSys AG happened on March 14, 2024 when Wells Fargo changed their price target from $17 to $18.25 for MorphoSys AG.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MorphoSys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MorphoSys was filed on March 14, 2024 so you should expect the next rating to be made available sometime around March 14, 2025.

While ratings are subjective and will change, the latest MorphoSys (MOR) rating was a downgraded with a price target of $17.00 to $18.25. The current price MorphoSys (MOR) is trading at is $17.94, which is within the analyst’s predicted range.